News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
News
Bio developments
More→
Teva and Sanofi’s IBD drug hits Phase 2 targets
By Helen Albert
Orexo and Abera collaborate to develop nasal powder vaccines
By Larissa Warneck-Silvestrin
SpliceBio gets FDA green light to start Phase 1/2 trial for inherited eye disease gene therapy
By Larissa Warneck-Silvestrin
Promotional features
More→
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
Paid for and content provided by Scorpius BioManufacturing
Is GMP grade good enough? What mRNA manufacturers need to know when buying raw materials
Paid for and in partnership with Thermo Fisher Scientific - Biosciences
Continuous bioprocessing set to revolutionize cGMP manufacturing of biologics
Paid for and content provided by Just – Evotec Biologics
AAVs – liquid treasure handled safely
Paid for and content provided by Single Use Support
Biopharma culture
More→
An overview of the biosimilars space
By Clara Rodriguez Fernandez
The FDA has approved Pfizer’s RSV vaccine Abrysvo for adults aged 18 to 59
By Larissa Worneck-Silvestrin
Innovations in mass spectrometry accelerate the shift toward precision medicine
By Clara Rodriguez Fernandez
Contract manufacturing & logistics
More→
Markets & regulation
More→
FDA approves first mesenchymal stromal cell therapy
By Clara Rodriguez Fernandez
Cell and gene therapy access model launches in US
By Helen Albert
Mergers & deals
More→
nChroma Bio formed by merging genetic medicine companies
By Helen Albert
Roche acquires CAR-T developer Poseida Therapeutics for $1.5 billion
By Clara Rodriguez Fernandez
AbbVie acquires Aliada Therapeutics in $1.4 billion deal
By Clara Rodriguez Fernandez